<p>Biotech Outsourcing Strategies 2012</p> <p><em>Discovery &amp; Early Development Tracks</em></p>

Welcome to the Biotech Outsourcing Strategies 2012 the leading outsourcing focused partnering event for biotech and pharmaceutical R&D outsourcing. For our 7th consecutive year BOS will be providing the platform for networking and partnering for stakeholders in outsourcing from discovery through to clinical development.

Who should attend BOS 2012?

BOS Events were established in 2006 to provide an outsourcing focused discussion forum and partnering meeting for biotech, pharma and the contract services community. The programme content and structure of the event is particularly aimed at virtual biotech and semi-virtual biotech who depend on strong, successful outsourcing relationships from target validation through lead optimisation, early scale up and into the clinic. BOS 2012 is relevant to R&D professionals with an outsourcing role in discovery, CMC and clinical operations.

BOS Event Formula

1 day only in duration BOS 2012 will consist of 3 core elements including: Presentations delivered by leading industry professionals and focused on outsourcing: Partnering, 1 to 1 meetings running in parallel to the programme and facilitated by use of partnering software made available to all attendees (participation in partnering meetings is optional and completely at the delegates discretion): Networking, our schedule for the day has evolved over the last 6 years to include ample time for informal networking and partnering over extended lunch, post event drinks reception and partnering breakfast for the early birds! 

BOS 2012 non-clinical track

Our non-clinical track for 2012 will cover discovery and early development. Presentations will cover discovery biology, lead optimisation, medicinal chemistry, drug substance early scale up, drug product formulation strategies and approaches to toxicology at the discovery/early development interface. The programme will largely focus on NCE (New Chemical Entity) CMC challenges.

BOS 2012 clinical track

The planned programme for our clinical track has been developed to address key issues in biotech clinical outsourcing and will cover topics including; outsourcing strategies for clinical development, one stop shop CRO v's discreet CRO providers, preferred supplier outsourcing relationships, outsourcing in developing economies, CRO selection and relationship management strategies, utilising technologies to enable efficiencies in site monitoring, ensuring maximum CRO attention for your project from a biotech perspective.

Please click here to register your interest, you will receive a warm welcome at BOS 2012 and we are confident you will find the day extremely beneficial and enjoyable